A systematic review on nanomedicine

Yasir Nawaz, Ishart Nazar, Luqman Hakeem, Ayesha Saddiqa, Luqman Hakeem, Hassnain Ahmad, Muhammad Saleem Khan, Muhammad Kaleem Ullah, Hafiza Rabia Shafiaq, Khadija Iqbal, Muhammad Waijad, Bilal Saeed


Nanomedicine is used to cure cancer of many tissues such as ovarian cancer and multiple myeloma. With the help of nanotechnology, the probability of failure or rejection of a transplant, an organ is reduced. Nanomedicine is one of the latest and better fields which is used for the treatment of tumors. Some of the methods used to produce nanoparticles are discussed here. Many nanoparticles are used for the benefit of humans. The solvent is subsequently dispersed in a surfactant's aqueous media, resulting in the formation of a film in an instant colloidal suspension called solvent displacement. This method can be used to achieve a pharmacological payload. Supersaturation and precipitation are required for the assembly and stability of drug nanoparticles. Shear and cavitation forces are also used to produce nanoparticles. The milling media is generating shear forces on impact, resulting in nanoparticles, the principle of size reduction. Extrusion is also used to generate nanoparticles. Hydrophobic drugs are converted directly into nanoparticles. The capacity to build nanocores with a wide range of functionalities is another key advantage of the HAylation process (a method to make nanoparticles). Determine medication, metabolism and hepatotoxicity in these models in nanomedicine have the potential to have a significant influence in the field. Red blood cells (RBCs), for example, are sensitive to substantial external flow pressures, and their inherent formability can be used as a biomarker to identify a range of RBC diseases. It is concluded that different nanoparticles are made to treat different kinds of diseases and to make different therapies for cancer etc. Now a day’s nanotechnology is the method that uses nanoparticles to cure diseases and provide a significant treatment approach to humans.


Keywords: Nanomedicine, Nanoparticles, Nanotherapeutics, Production of Nanomedicine, Nanotechnology, Theranostic Nanoparticles

Full Text:



Caron, I., S. Papa, F. Rossi, G. Forloni and P. Veglianese, 2014. Nanovector-mediated drug delivery for spinal cord injury treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 6(5): 506-515.

d'Angelo, M., V. Castelli, E. Benedetti, A. Antonosante, M. Catanesi, R. Dominguez-Benot, G. Pitari, R. Ippoliti and A. Cimini, 2019. Theranostic nanomedicine for malignant gliomas. Front Bioeng Biotechnol, 7: 325.

Demming, A., 2013. Nanotechnological selection. Nanotechnology, 24(2): 020201.

Dong, X., Z. Sun, J. Liang, H. Wang, D. Zhu, X. Leng, C. Wang, D. Kong and F. Lv, 2022. Corrigendum to "a visible fluorescent nanovaccine based on functional genipin crosslinked ovalbumin protein nanoparticles" [nanomedicine: Nanotechnology, biology, and medicine 14 (2018) 1087-1098/nano 1763]. Nanomedicine: 102524.

Egorov, E., C. Pieters, H. Korach-Rechtman, J. Shklover and A. Schroeder, 2021. Robotics, microfluidics, nanotechnology and ai in the synthesis and evaluation of liposomes and polymeric drug delivery systems. Drug deliv transl research, 11(2): 345-352.

Hajialyani, M., D. Tewari, E. Sobarzo-Sanchez, S. M. Nabavi, M. H. Farzaei and M. Abdollahi, 2018. Natural product-based nanomedicines for wound healing purposes: Therapeutic targets and drug delivery systems. International journal of Nanomedicine, 13: 5023-5043.

Jain, K. K., 2005. Nanotechnology in clinical laboratory diagnostics. Clinnical Chemical Acta, 358(1-2): 37-54.

Kenzaoui, B. H., C. C. Bernasconi, H. Hofmann and L. Juillerat-Jeanneret, 2012. Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomedicine (Lond), 7(1): 39-53.

Kumar, A. and A. Nanda, 2021. Nano cocrystals: Crystal engineering from a nanotechnological perspective. Current pharma describe, 27(21): 2445-2453.

Ma, X. and S. Sanchez, 2017. Self-propelling micro-nanorobots: Challenges and future perspectives in nanomedicine. Nanomedicine (Lond), 12(12): 1363-1367.

Martin Gimenez, V. M., D. E. Kassuha and W. Manucha, 2017. Nanomedicine applied to cardiovascular diseases: Latest developments. Theritical adventure cardiovasc Diseases, 11(4): 133-142.

Ottonelli, I., J. T. Duskey, A. Rinaldi, M. V. Grazioli, I. Parmeggiani, M. A. Vandelli, L. Z. Wang, R. K. Prud'homme, G. Tosi and B. Ruozi, 2021. Microfluidic technology for the production of hybrid nanomedicines. Pharmaceutics, 13(9).

Pai, N. P., A. Karellis, J. Kim and T. Peter, 2020. Modern diagnostic technologies for hiv. Lancet HIV, 7(8): e574-e581.

Paliwal, R., R. J. Babu and S. Palakurthi, 2014. Nanomedicine scale-up technologies: Feasibilities and challenges. AAPS PharmSciTech, 15(6): 1527-1534.

Rodrigues, R. O., P. C. Sousa, J. Gaspar, M. Banobre-Lopez, R. Lima and G. Minas, 2020. Organ-on-a-chip: A preclinical microfluidic platform for the progress of nanomedicine. Small, 16(51): e2003517.

Salvador-Morales, C. and P. Grodzinski, 2022. Nanotechnology tools enabling biological discovery. ACS Nano.

Tan, S., L. Wang, H. Liu, H. Wu and Q. Liu, 2016. Single nanoparticle translocation through chemically modified solid nanopore. Nanoscale research letter, 11(1): 50.

Tosi, G., J. Thomas Duskey, M. Angela Vandelli and B. Ruozi, 2021. Nanomedicines for brain diseases: Where we are and where we are going. Ther Deliv, 12(9): 631-635.

DOI: https://doi.org/10.33865/wjb.007.01.0461


  • There are currently no refbacks.

Copyright (c) 2022 Yasir Nawaz, Ishart Nazar, Luqman Hakeem, Ayesha Saddiqa, Luqman Hakeem, Hassnain Ahmad, Muhammad Saleem Khan, Muhammad Kaleem Ullah, Hafiza Rabia Shafiaq, Khadija Iqbal, Muhammad Waijad, Bilal Saeed

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Print ISSN: 2522-6746 : Online ISSN: 2522-6754

1. How to register 
2. How to prepare a manuscript before submission 
3. How to submit a paper 
4. How to check the review status of a paper
5. How to check the plagirisim or similarity report